Skip to main content
Press release November 5, 2026

Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting

Biohaven Ltd. (BHVN)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site